In the United States, thyroid cancer incidence (along with liver cancer) is increasing more rapidly than any other malignancy, rising nearly threefold from 1980 to 2006. Improved diagnosis has been proposed by some as the major reason for this change, while others contend that additional factors also account for the increase. Among U.S. states, 2001–2005 age-adjusted thyroid cancer incidence rates vary from 5.4 to 12.8 per 100,000. County-specific incidence data, available for the first time, document that most U.S. counties with the highest thyroid cancer incidence are in a contiguous area of eastern Pennsylvania, New Jersey, and southern New York State. Exposures to radioactive iodine emissions from 16 nuclear power reactors within a 90-mile radius in this area indicate that these emissions are a likely etiological factor in rising thyroid cancer incidence rates.
ReynoldsR. M.Changing trends in incidence and mortality in Scotland. Clin. Endocrinol.62(2):156–162, 2005.
3.
LeenhardtL.GrosclaudeP.Cherie-ChallineL.Increased incidence of thyroid carcinoma in France: A true epidemic or thyroid nodule management effects?Rep. Fr. Thyroid Cancer Committee14(12):1056–1060, 2004.
DuijpensJ. L.Thyroid cancer in southeastern Netherlands, 1970–1989: Trends in incidence, treatment, and survival. Neerl. Tijdschr. Geneeskd.138(9):464–468, 1994.
6.
RoskowskaH.GorynskiP.Thyroid cancer in Poland in 1980–2000. Przegl. Epidemiol.58(2):269–276, 2004.
7.
MurbethS.Thyroid cancer has increased in the adult populations of countries affected by Chernobyl fallout. Med. Sci. Monit.10(7):300–306, 2004.
8.
VerkooijenH. M.Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control14(1): 13–17, 2003.
9.
FaheyT. J.ReeveT. S.DelbridgeL.Increasing incidence and changing presentation of thyroid cancer over a 30-year period. Br. J. Surg.82(4):518–520, 1995.
10.
dos Dantos SilvaI.SwerdlowA. J.Thyroid cancer epidemiology in England and Wales: Time trends and geographical distribution. Br. J. Cancer67(2):330–340, 1993.
11.
LiuS.Increasing thyroid cancer incidence in Canada 1970–1996: Time trends and age-period-cohort effects. Br. J. Cancer85(9):1335–1339, 2001.
12.
DaviesL.WelchH. G.The increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA295(18):2164–2168, 2006.
13.
EnewoldL.Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol. Biomarkers Prev. 18(3):784–791, 2009.
14.
DasB.FeuerE. J.MariottoA.Geographic association between mammography use and mortality reduction in the US. Cancer Causes Control16(6):691–699, 2005.
15.
JemalA.Geographic variation in prostate cancer mortality rates among white males in the United States. Ann. Epidemiol.10(7):470, 2000.
16.
HaoY.U.S. Congressional district cancer death rates. Int. J. Health Geogr. 23(5):28, 2006.
17.
HuangL.PickleL. W.DasB.Evaluating spatial methods for investigating global clustering and cluster detection of cancer cases. Stat. Med.27(25):5111–5142, 2008.
18.
KulldorffM.Cancer map patterns: Are they random or not?Am. J. Prev. Med.30(2, Suppl.):S37–S49, 2006.
StewartS. L.Surveillance for cancers associated with tobacco use—United States, 1999–2004. MMWR CDC Surveill. Summ.57(8):1–33, 2008.
21.
LiJ.Cancer incidence among children and adolescents in the United States, 2001–2003. Pediatrics121(6):470–477, 2008.
22.
KilfoyB. A.International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control [Epub. ahead of print], 2008.
23.
NagatakiS.NystromE.Epidemiology and primary prevention of thyroid cancer. Thyroid12(10):889–896, 2002.
24.
JablonS.Cancer in Populations Living Near Nuclear Facilities. National Cancer Institute, NIH Pub. No. 90-874. Government Printing Office, Washington, DC, 1990.
25.
CochranT. B.NorrisR. S.United States Nuclear Tests, July 1945 to December 1992. Natural Resources Defense Council, Washington, DC, 1994.
26.
National Cancer Institute. Estimated Exposures and Thyroid Doses Received by the American People from Iodine 131 in Fallout Following Nevada Atmospheric Nuclear Bomb Tests: A Report from the National Cancer Institute. U.S. Department of Health and Human Services, Bethesda, MD, 1997. http://spike.nci.nih.gov.
27.
Institute of Medicine and National Research Council. Exposure of the American People to Iodine-131 from Nevada Atomic Bomb Tests: Review of the National Cancer Institute Report and Public Health Implications. National Academy of Sciences, Washington, DC, 1998.
28.
CampbellJ. E.MurthyG. K.Summary of Results from the Raw Milk Sampling Program, June 1957–April 1963. Radiological Health Data, October 1963, pp. 511–519. U.S. Public Health Service, Washington, DC, 1963.
29.
SchneiderA. B.Carcinoma of follicular epithelium. In Werner and Ingbars The Thyroid: A Fundamental and Clinical Test, Ed. 6, ed. BravermanL. E.UtigerR. D., J. B. Lippincott, Philadelphia, 1991.
30.
RonE.A population-based case-control study of thyroid cancer. J. Natl. Cancer Inst. 79:1–12, 1987.
31.
Office of Radiation Programs. Environmental Radiation Data. Quarterly reports. U.S. Environmental Protection Agency, Montgomery, AL, 1986.
32.
TichlerJ.DotyK.LucadamoK.Radioactive Materials Released from Nuclear Power Plants, 1979 Report. NUREG/CR-2907. Brookhaven National Laboratory, Upton, NY, 1981.
33.
WahlenM.Radioactive plume from the Three Mile Island accident: Xenon-133 in air at a distance of 375 kilometers. Science207:639–640, 1980.
34.
ArmentroutC. Report in In Re Three Mile Island Litigation Cases Consolidated II, Civil Action No. I:CV-88-1452, Harrisburg PA, U.S. District Court for the Middle District of Pennsylvania, January 5, 1996.
